These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 15563666

  • 1. MUC4 is increased in high grade intraepithelial neoplasia in Barrett's oesophagus and is associated with a proapoptotic Bax to Bcl-2 ratio.
    Bax DA, Haringsma J, Einerhand AW, van Dekken H, Blok P, Siersema PD, Kuipers EJ, Kusters JG.
    J Clin Pathol; 2004 Dec; 57(12):1267-72. PubMed ID: 15563666
    [Abstract] [Full Text] [Related]

  • 2. Suppression of apoptosis does not foster neoplastic growth in Barrett's esophagus.
    Soslow RA, Remotti H, Baergen RN, Altorki NK.
    Mod Pathol; 1999 Mar; 12(3):239-50. PubMed ID: 10102608
    [Abstract] [Full Text] [Related]

  • 3. Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus.
    Glickman JN, Blount PL, Sanchez CA, Cowan DS, Wongsurawat VJ, Reid BJ, Odze RD.
    Hum Pathol; 2006 Oct; 37(10):1304-15. PubMed ID: 16949933
    [Abstract] [Full Text] [Related]

  • 4. Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
    Brabender J, Lord RV, Danenberg KD, Metzger R, Schneider PM, Park JM, Salonga D, Groshen S, Tsao-Wei DD, DeMeester TR, Hölscher AH, Danenberg PV.
    J Surg Res; 2001 Aug; 99(2):301-6. PubMed ID: 11469901
    [Abstract] [Full Text] [Related]

  • 5. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance.
    Andrianifahanana M, Moniaux N, Schmied BM, Ringel J, Friess H, Hollingsworth MA, Büchler MW, Aubert JP, Batra SK.
    Clin Cancer Res; 2001 Dec; 7(12):4033-40. PubMed ID: 11751498
    [Abstract] [Full Text] [Related]

  • 6. Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study.
    Arul GS, Moorghen M, Myerscough N, Alderson DA, Spicer RD, Corfield AP.
    Gut; 2000 Dec; 47(6):753-61. PubMed ID: 11076872
    [Abstract] [Full Text] [Related]

  • 7. Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus.
    Krishnadath KK, Tilanus HW, van Blankenstein M, Bosman FT, Mulder AH.
    J Pathol; 1995 Feb; 175(2):175-80. PubMed ID: 7738712
    [Abstract] [Full Text] [Related]

  • 8. The homeodomain protein CDX2 is an early marker of Barrett's oesophagus.
    Moons LM, Bax DA, Kuipers EJ, Van Dekken H, Haringsma J, Van Vliet AH, Siersema PD, Kusters JG.
    J Clin Pathol; 2004 Oct; 57(10):1063-8. PubMed ID: 15452161
    [Abstract] [Full Text] [Related]

  • 9. Clinical impact of MUC1 and MUC4 expression in Barrett-associated oesophageal adenocarcinoma.
    Piessen G, Wacrenier A, Briez N, Triboulet JP, Van Seuningen I, Mariette C.
    J Clin Pathol; 2009 Dec; 62(12):1144-6. PubMed ID: 19946103
    [Abstract] [Full Text] [Related]

  • 10. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
    Yamamoto S, Kijima H, Hara T, Chino O, Shimada H, Tanaka M, Inokuchi S, Makuuchi H.
    Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
    [Abstract] [Full Text] [Related]

  • 11. Expression of MUC1 and MUC2 mucin gene products in Barrett's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation.
    Chinyama CN, Marshall RE, Owen WJ, Mason RC, Kothari D, Wilkinson ML, Sanderson JD.
    Histopathology; 1999 Dec; 35(6):517-24. PubMed ID: 10583575
    [Abstract] [Full Text] [Related]

  • 12. Survivin, a potential biomarker in the development of Barrett's adenocarcinoma.
    Vallböhmer D, Peters JH, Oh D, Kuramochi H, Shimizu D, Demeester SR, Hagen JA, Chandrasoma PT, Danenberg KD, DeMeester TR, Danenberg P.
    Surgery; 2005 Oct; 138(4):701-6; discussion 706-7. PubMed ID: 16269299
    [Abstract] [Full Text] [Related]

  • 13. bcl-2 protein expression in the Barrett's metaplasia-dysplasia-carcinoma sequence.
    Goldblum JR, Rice TW.
    Mod Pathol; 1995 Oct; 8(8):866-9. PubMed ID: 8552577
    [Abstract] [Full Text] [Related]

  • 14. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study.
    Beales IL, Ogunwobi O, Cameron E, El-Amin K, Mutungi G, Wilkinson M.
    BMC Cancer; 2007 Jun 08; 7():97. PubMed ID: 17559672
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Mucin gene expression and cell differentiation in human normal, premalignant and malignant esophagus.
    Guillem P, Billeret V, Buisine MP, Flejou JF, Lecomte-Houcke M, Degand P, Aubert JP, Triboulet JP, Porchet N.
    Int J Cancer; 2000 Dec 15; 88(6):856-61. PubMed ID: 11093805
    [Abstract] [Full Text] [Related]

  • 17. Differential expression of mucins 1-6 in papillary thyroid carcinoma: evidence for transformation-dependent post-translational modifications of MUC1 in situ.
    Magro G, Schiappacassi M, Perissinotto D, Corsaro A, Borghese C, Belfiore A, Colombatti A, Grasso S, Botti C, Bombardieri E, Perris R.
    J Pathol; 2003 Jul 15; 200(3):357-69. PubMed ID: 12845632
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of methylene blue-directed biopsies and four-quadrant biopsies in the detection of high-grade intraepithelial neoplasia and early cancer in Barrett's oesophagus.
    Gossner L, Pech O, May A, Vieth M, Stolte M, Ell C.
    Dig Liver Dis; 2006 Oct 15; 38(10):724-9. PubMed ID: 16911879
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.